Funding

CURRENT RESEARCH FUNDING: PRINCIPAL INVESTIGATOR

R01 AI-57661, NIAID,                                              

R01 AI106002-01

Molecular Determinants of Cross-Reactive Antibody Response to Influenza in Humans

PI: James E. Crowe, Jr.

08/15/2012 – 07/31/2016

The purpose of this grant is to isolate human monoclonal antibodies to influenza, and to study influenza specific human B cell repertoires, with emphasis on broadly cross-reactive antibodies.

 

Defense Threat Reduction Agency (Department of Defense)

Award Number: HDTRA1-13-1-0034

"Human monoclonal antibodies against Ebola and Marburg viruses"

Role: PI

04/01/2013- 03/31/2018

The purpose of this award is to isolate and study human monoclonal antibodies to filoviruses.

 

HHSN272200900047C Contract, NIAID/NIH

"Genetic and structural basis for virus neutralization"

B Cell Epitope Discovery and Mechanisms of Antibody Protection

Role: PI

09/30/2009 -09/29/2014  

This is a B cell epitope mapping contract focused on H5 influenza and poxvirus epitopes

 

HHSN272200900055C Contract, NIAID/NIH (PI: Doranz; Integral Molecular)   

Role: Vanderbilt PI of subcontract

Subcontract to develop human monoclonal antibodies to hepatitis C and Chikungunya viruses

07/01/2012-06/30/2013

 

NIAID, NIH ARRA administrative award for supplemental funding                      "Alphavirus-based Vaccine for Prevention of MPV Infection"

Role: PI

7/26/10 - 7/25/2012

The purpose of this supplement to our Regional Centers of Excellence award is to support the production of experimental vaccine lots for RSV and MPV with testing for immunogenicity and protective efficacy in nonhuman primates.

 

Defense Threat Reduction Agency (Department of Defense)

Award Number: HDTRA1-10-1-0067

"Molecular and structural basis for fine specificity of antiviral antibodies"

Role: PI

04/01/2013- 03/31/2018

The purpose of this award is to isolate and characterize human monoclonal antibodies to Ebola and Marburg viruses form survivors of those infections.

 

March of Dimes Foundation

"Epithelial cell stress response and RSV infection"

Role: PI

2010-2013

The purpose of this grant is to study the role of stress granule formation in RSV replication in epithelial cells.

 

 

5T32 AI 89554, NIAID, NIH

"Virology Training Program"

Role: PI of the Training Program, and Faculty Mentor

05/01/2010-04/30/2015

This is a training grant program to train PhD candidate students in molecular and cellular virology research.

 

 

CURRENT RESEARCH FUNDING: CO-INVESTIGATOR

 

R01 AI 059694, NIAID, NIH

Bioinformatics Strategies: Biodefense Vaccine Research

PI: Jason Moore, Dartmouth

My role: Consultant

2009-2014

 

N01 AI 25462, Vaccine Treatment and Evaluation Unit, NIAID, NIH

Evaluation of control measures against infectious diseases other than AIDS

Co-Investigator; (PI is Kathryn Edwards)

11/01/2007 – 10/31/2014

This is a vaccine testing center contract. The bulk of the work in the contract currently is aimed at testing vaccines in adults for purposes of biodefense. My role is to supervise and conduct immunology studies, especially concerning H3N2v influenza immunity.

P30 AI-54999, NIAID/ N

U54 AI 057157, NIAID, NIH

Region IV Southeast Regional Center of Excellence in Emerging Infections and Biodefense

Co-Investigator; (PI is Fred Sparling [UNC-CH])

09/04/09 – 2/28/14

This award is a multi-institutional award to support regional expertise in biodefense. I am the project director for Project 9.1, "Genetic and Structural Determinants of Human Antibodies to Dengue Virus."

 

P01 AI 078064, NIAID, NIH

Programming HIV Immunity for Broadly Neutralizing Antibodies by Vaccination

Co-Investigator; (PI is Nancy Haigwood [Oregon Primate Center]; VUMC PI is Spyros Kalams)

2/1/09 – 1/31/14                                                         

The overall goal is to design novel vaccines based on Env genes derived from virions (plasma RNA, not cellular DNA) from HIV-infected subjects who develop broad Nabs in an accelerated fashion (<3 years). Our part of the project is to make human mAbs from HIV-infected individuals.

 

R01 AI 090656 NIAID, NIH (HITIT award)                                        

Broadly Reactive Antibodies against Chimeric Virus-Host Antigens

PI: Donald Forthal, UC-Irvine

07/01/2010 - 06/30/2014

Role: Co-Investigator.

The purpose of this grant is to determine whether humans infected with HIV make antibody responses to antigens that are chimeras of virus and host proteins.

 

R01 GM 094198, NIGMS, NIH

Single RNA Sensitive Probes for Studying Viral Replication and Budding

PI: Philip Santangelo, Georgia Tech

Role: Co-investigator

7/1/2010-6/30/2015

The purpose of this grant is to develop novel imaging probes for RNA virus genomes in live cells.

 

5P30 DK058404-11, NIH/NIDDK (Peek)                                                   

Molecular and Cellular Basis of Digestive Disease
06/1/2012 - 05/31/2017                                                                               

Role: Core Director                                                                               

This is our Digestive Diseases Research Center. My role is to direct the flow cytometry shared resource.

 

5P30 CA068485-15, NIH/NCI (Pietenpol)                                                  

Cancer Center Support Grant

09/01/2010-08/31/2015

This is a Cancer Center Support Grant from NCI that supports the Vanderbilt Ingram Cancer Center. I am Director of the Flow Cytometry Shared Resource.

 

R21 AI092268, NIAID/NIH

Epitope shifting and antibody maturation during rotavirus infection

PI: Ben Spiller,

My role: Co-investigator

 

R21 AI098592, NIAID/NIH (Spearman/Emory)                                                                            

HIV-specific B cell repertoire in humans following cross-clade immunization

07/01/2012-06/30/2014 

Role: Co-Investigator